Childhood cancers, though rare, require specialized care due to their unique characteristics and varied presentations. Dr.

Wells Fargo stands firm on its buy rating for The Progressive Corporation. Analyst Elyse Greenspan raised the price target to $333, citing efficient management strategies and a solid expense control ...